Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $9.52 USD
Change Today +0.71 / 8.06%
Volume 4.4M
ZIOP On Other Exchanges
As of 8:10 PM 05/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jonathan J. Lewis M.D., Ph.D.

Chief Executive Officer and Director, ZIOPHARM Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Jonathan J. Lewis, MD., PhD., has been the Chief Executive Officer of Ziopharm Oncology, Inc. since January 2004. Dr. Lewis served as the Chief Medical Officer of Ziopharm Oncology, Inc. from June 2008 to June 2011. He served as the Chief Executive Officer of Ziopharm Inc. since January 2004. He served as the Chief Medical Officer of Antigenics Inc. from June 2000 to Noveber 2003. He joined Antigenics from Memorial Sloan-Kettering Cancer Center in New York, where ...

Read Full Background

Corporate Headquarters*

Parris Building 34
Boston, Massachusetts 02129

United States

Phone: 617-259-1970
Fax: 617-241-2855

Board Members Memberships*

Chief Executive Officer and Director
Former Director, Chairman of Compensation & Stock Option Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee


University of the Witwatersrand
University of the Witwatersrand
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$700,000

Stock Options*

All Other Compensation$79,628
Exercised Options268,653
Exercised Options Value$1,147,148
Exercisable Options1,331,265
Exercisable Options Value$1,737,141
Unexercisable Options870,000
Unexercisable Options Value$846,400
Total Value of Options$3,730,688
Total Number of Options2,469,918

Total Compensation*

Total Annual Cash Compensation$779,628
Total Short Term Compensation$700,000
Other Long Term Compensation$79,628
Total Calculated Compensation$2,055,868
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZIOP:US $9.52 USD +0.71


Kevin T. Conroy Chairman of The Board, Chief Executive Officer and President
Exact Sciences Corporation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIOPHARM ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at